Control group (n = 19)

p value

Intervention group (n = 29)

p value

Baseline

After 2 months

Baseline

After 2 months

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

TG (mg/dL)

69.7 ± 29.2

78.6 ± 42.0

0.445

73.5 ± 42.9

76.9 ± 48.5

0.660

HDL-C (mg/dL)

59.6 ± 12.1

58.2 ± 10.5

0.242

58.4 ± 12.6

59.5 ± 11.5

0.432

LDL-C (mg/dL)

91.5 ± 22.1

101.8 ± 23.6

<0.001^***

90.4 ± 28.8

100.2 ± 27.3

<0.001^***

Total-C (mg/dL)

165.3 ± 25.3

176.3 ± 23.3

0.007^**

164.7 ± 33.7

177.1 ± 25.9

<0.001^***

Glucose (mg/dL)

89.0 ± 6.4

87.3 ± 6.3

0.175

89.6 ± 4.0

87.6 ± 4.2

0.019^*

HbA1c (%)

4.7 ± 0.2

4.8 ± 0.2

0.005^**

4.7 ± 0.2

4.8 ± 0.2

0.660

Insulin (µIU/mL)

9.2 ± 4.5

9.5 ± 4.0

0.820

8.1 ± 4.3

7.8 ± 4.0

0.589

HOMA-IR

2.1 ± 1.1

2.1 ± 1.0

0.992

1.9 ± 1.2

1.8 ± 1.1

0.376

Homocysteine (µmol/L)

11.8 ± 6.8

13.0 ± 8.2

0.015^*

11.9 ± 8.9

11.7 ± 6.6

0.619

Folic acid (ng/mL)

5.1 ± 1.5

6.3 ± 2.2

0.010^*

5.1 ± 1.6

6.9 ± 2.1

<0.001^***

Uric acid (mg/dL)

5.1 ± 1.4

5.0 ± 1.3

0.678

5.1 ± 1.2

5.1 ± 1.2

0.518

Hs-CRP (mg/dL)

0.7 ± 1.4

0.2 ± 0.3

0.129

0.5 ± 1.0

0.3 ± 0.4

0.301

RBCs (10⁴ cells/µL)

469.3 ± 41.8

468.8 ± 40.9

0.949

458.1 ± 43.1

466.6 ± 43.2

0.059

Hemoglobin (g/dL)

14.0 ± 1.8

14.2 ± 1.4

0.298

13.5 ± 1.7

14.1 ± 1.4

0.006^**

Hematocrit (%)

42.4 ± 5.1

42.3 ± 4.0

0.821

41.0 ± 4.6

42.2 ± 3.6

0.037^*